Nov 13 (Reuters) - Innovate Biopharmaceuticals Inc INNT.O :
* RDD PHARMA ENTERS INTO NON-BINDING LETTER OF INTENT TO
ACQUIRE
NAIA RARE DISEASES, STRENGTHENING GASTROENTEROLOGY ORPHAN
DISEASE PIPELINE
* RDD PHARMA - CLOSING OF TRANSACTION ANTICIPATED TO OCCUR
AFTER
CONSUMMATION OF PROPOSED MERGER OF RDD, INNOVATE
BIOPHARMACEUTICALS
* RDD PHARMA - NAIA WILL RECEIVE CASH AND SHARES IN 9 METERS
BIOPHARMA SUBJECT TO CLOSING OF INNT MERGER
* RDD PHARMA - CORPORATE HEADQUARTERS FOR COMBINED COMPANY
WILL BE
LOCATED IN RALEIGH, NORTH CAROLINA
Source text for Eikon: ID:nPn6hC8HRa
Further company coverage: INNT.O
((Reuters.Briefs@thomsonreuters.com;))